GMP Division of
Seda Pharmaceutical Development Services
Search
Services
Facilities
People
News
Careers
Contact
Contact us
CellCentric’s first-in-class p300/CBP inhibitor CCS1477 publishes in Cancer Discovery
View
CellCentric’s first-in-class p300/CBP inhibitor CCS1477 publishes in Cancer Discovery
View
Paul Dickinson Presents: Developing Clinically Relevant Dissolution Specifications in APS Virtual Webinar Series
Categories
Publications
Drug Developments
Appointments
Events
General
Recent
July 2025
June 2025
March 2025
July 2024
May 2024
March 2024
February 2024
January 2024
November 2023
October 2023
August 2023
July 2023
April 2023
March 2023
February 2023
January 2023
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
September 2020
August 2020
Archive
2025
2024
2023
2022
2021
2020